# Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient

> **NCT04595136** · PHASE1,PHASE2 · UNKNOWN · sponsor: **United Medical Specialties** · enrollment: 60 (estimated)

## Conditions studied

- SARS-CoV-2 Infection

## Interventions

- **DRUG:** Drug COVID19-0001-USR
- **DRUG:** normal saline

## Key facts

- **NCT ID:** NCT04595136
- **Lead sponsor:** United Medical Specialties
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-02
- **Primary completion:** 2021-07-30
- **Final completion:** 2021-08-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04595136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04595136, "Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04595136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*